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Abstract
We describe methods for rapid sequencing of the entire human mitochondrial genome (mtgenome), which involve long-
range PCR for specific amplification of the mtgenome, pyrosequencing, quantitative mapping of sequence reads to identify
sequence variants and heteroplasmy, as well as de novo sequence assembly. These methods have been used to study 40
publicly available HapMap samples of European (CEU) and African (YRI) ancestry to demonstrate a sequencing error rate
,5.6361024, nucleotide diversity of 1.661023 for CEU and 3.761023 for YRI, patterns of sequence variation consistent with
earlier studies, but a higher rate of heteroplasmy varying between 10% and 50%. These results demonstrate that next-
generation sequencing technologies allow interrogation of the mitochondrial genome in greater depth than previously
possible which may be of value in biology and medicine.
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Introduction
The first complete human ‘genome’ sequenced was that of the
mitochondrion in 1981 [1]. Since then, over 8,250 complete
human and 3,220 complete non-human vertebrate mitochondrial
genomes have been sequenced (http://www.ncbi.nlm.nih.gov).
These contributions have come from numerous laboratories,
where obtaining the complete sequence of even the ,16.5 kb
circular mitochondrial genome has been labor intensive and
expensive. As an exemplar, it would be desirable to obtain this
sequence on tens of thousands of samples in a simple, inexpensive,
yet accurate manner. Beyond enriching many aspects of human
biology, this development could be considered as a prelude, or
even as a prerequisite, to sequence-based individualized medicine.
Indeed, the mitochondrial genome, despite its unique structure
and function, is an excellent ‘model system’ to identify and solve
the technical, biological and medical problems that genomic
medicine will encounter.
The mitochondrial genome (mtgenome) has multiple attractive
structural and functional features. First, it is small at 16,569 bp
(revised Cambridge Reference Sequence, rCRS) [2]. Second, it is
divided into a small (6.8%) non-coding displacement loop (D-loop)
or control region which provides the origin for mtDNA
replication, and a large (93.2%) coding region compactly housing
37 genes (22 tRNAs, 13 proteins and 2 rRNAs) that encode
proteins critical to the electron transport chain [1]. The unique
biochemical functions of the mitochondria and its high functional
content suggest that a higher fraction of mitochondrial, as
compared to nuclear, mutations is likely to be functionally
deleterious and have distinct phenotypes. Consequently, we have
an enhanced possibility of understanding the logic of how
sequence variation affects biochemical functions and organismal
phenotypes. Third, depending on cell type, each cell contains
hundreds or more of mitochondria, each mitochondrion harbor-
ing 2–10 genomes. Thus, the functional consequences of
mtgenome variation acutely depend on the tissue, and are thus a
model for all genes.
Genetic variation in the mtgenome has been critical to
demonstrating its unique features of matrilineal inheritance
[3,4], lack of recombination [5], higher variability than the
nuclear genome [6,7] and hypervariability within the D-loop as
compared to the rest of the mtgenome [8,9]. These features have
allowed delineation of mitochondrial haplotypes and haplogroups
along maternal lines of descent in different human populations,
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and greatly contributed to our current understanding of human
population structure and evolution. In turn, mitochondrial
haplogroups have become a marker of an individual’s ancestry.
A surprising aspect of the mitochondrial genome has been its
unusually large impact on human disease given its small size,
owing to its high coding ratio and high mutation rate. The impact
of mutations in the mtgenome on tissues with high-energy needs,
such as muscle, has long been recognized in genetic disorders such
as myoclonus epilepsy with ragged red fibers (MERRF) and
Leber’s hereditary optic neuropathy (LHON) [10,11]. More
broadly, mutations in the mtgenome have been identified in, or
associated with, many complex disorders such as cancer,
cardiovascular disease, neurodegeneration, diabetes and hearing
loss [10,12–16]; accumulation of mutations in the mitochondrial
genome is a natural part of aging [17,18] and the development of
tumors as well [12]. Therefore, improved methods to sequence the
mtgenome are of value to both biology and medicine.
The 100–1,000-fold higher mutation rate in mitochondria, as
compared to the nuclear genome, is owing to the lack of a DNA
repair system within the organelle [19]. Thus, alterations in the
mtgenome sequence occur frequently, visualized as two or more
mitochondrial genomes of different sequence within a single
human. Such ‘heteroplasmy’ has long been considered rare but it
is one major explanation for the variation in phenotypes between
maternally related individuals with a deleterious mitochondrial
mutation since different individuals within the same maternal
lineage may harbor different proportions of wildtype to mutant
mitochondria. However, strictly on theoretical grounds, hetero-
plasmy must be common since each oocyte has multiple
mitochondria, as compared to the single nuclear genome.
Therefore, any new mutation has a significant probability of
being lost through mitochondrial segregation in the daughter cells
after fertilization (mitochondrial ‘‘drift’’) and needs to be balanced
by additional mutations to allow variation. This may be a second
reason for the higher mitochondrial mutation rate observed
through heteroplasmy in all tissues. Indeed, some have proposed
that, under the ‘‘mutation-drift-selection’’ scenario, heteroplasmy
should be the default state for mtDNA in all tissues of the body
from mitochondrial segregation of inherited variation or from
somatic mutation [20]. Indeed, all extant mitochondrial polymor-
phisms must have gone through a heteroplasmic state after their
origin by mutation.
A number of studies have demonstrated heteroplasmy, but its
mechanism and incidence in the general population remains
unknown since the detection of heteroplasmy has been hindered
by the resolution of available sequencing technologies. While
Sanger sequencing allows for complete coverage of the mtgenome,
it is limited by the lack of deep coverage and low sensitivity for
heteroplasmy detection when it is much less than 50% [21]. The
Affymetrix Mitochip Array 2.0 containing the full mtDNA sense
and antisense sequences tiled on an array has been successfully
used in our laboratory for full mtgenome sequencing with slightly
improved heteroplasmy detection [22,23]. However, neither of
these technologies allows the assessment of individual mitochon-
drial molecules. In contrast, next generation sequencing technol-
ogy is an excellent tool for obtaining the mtgenome sequence and
its heteroplasmic sites rapidly and accurately since it allows deep
coverage of the genome through multiple independent sequence
reads. In fact, two recent studies demonstrate that the degree of
heteroplasmy can vary across an order of magnitude (typically
,5% but occasionally .50%) [24] and multiple sites with the
mtgenome have heteroplasmy rates .10% [25].
In this study, we present the complete mitochondrial genomic
sequence and heteroplasmic status of 40 samples from the
International HapMap Project [26] using the next-generation
454 GS FLX pyrosequencing platform. The samples include 20
individuals from the CEU (European ancestry) and 20 individuals
from the YRI (African ancestry) reference panels; these are
mtgenome sequences isolated without any contamination from
nuclear embedded numts (see results) and from publicly available
reference samples. The availability of such reference samples is
critical as the samples could serve as a basis for reproducing and
benchmarking new sequencing technologies. To enable analyses,
we developed novel sequence processing and analysis algorithms,
both for mapping against the reference sequence and for de novo
assembly, for confident determination of the mitochondrial
sequence. Our analyses demonstrate sequence accuracy of near
100%, nucleotide diversity of 1.661023 for CEU and 3.761023
for YRI, patterns of sequence variation consistent with earlier
studies, but a high rate of heteroplasmy varying between 10% and
50%.
Results
Sequencing of Reference HapMap Samples
Twenty-two unique CEU (European ancestry) and twenty-two
unique YRI (African ancestry) samples from the International
HapMap Project [26], including two sets of duplicates for each
population (CEU: NA10851, NA10856; YRI: NA18500 &
NA18503), were sequenced. The DNA used was enriched for
mitochondrial sequences by long range PCR (LPCR) of three ,5–
6 kb segments using mtgenome-specific primers. Although mito-
chondrial sequencing using total cellular DNA is possible and easy,
and is being routinely performed with heteroplasmy detection
[27][28], we avoided this approach because the human nuclear
genome has .1,200 non-functional mtgenome fragments (numts)
[29] and mitochondrial pseudogenes that complicate mtgenome
sequence assembly and introduces numerous polymorphism and
heteroplasmic artifacts. Thus, despite its simplicity it is quite
Author Summary
This manuscript details a novel algorithm to evaluate high-
throughput DNA sequence data from whole mitochondrial
genomes purified from genomic DNA, which also contains
multiple fragmented nuclear copies of mtgenomes
(numts). 40 samples were selected from 2 distinct
reference (HapMap) populations of African (YRI) and
European (CEU) origin. While previous technologies did
not allow the assessment of individual mitochondrial
molecules, next-generation sequencing technology is an
excellent tool for obtaining the mtgenome sequence and
its heteroplasmic sites rapidly and accurately through
deep coverage of the genome. The computational
techniques presented optimize reference-based align-
ments and introduce a new de novo assembly method.
An important contribution of our study was obtaining high
accuracy of the resulting called bases that we accom-
plished by quantitative filtering of reads that were error
prone. In addition, several sites were experimentally
validated and our method has a strong correlation
(R2 = 0.96) with the NIST standard reference sample for
heteroplasmy. Overall, our findings indicate that one can
now confidently genotype mtDNA variants using next-
generation sequencing data and reveal low levels of
heteroplasmy (.10%). Beyond enriching our understand-
ing and pathology of certain diseases, this development
could be considered as a prelude to sequence-based
individualized medicine for the mtgenome.
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erroneous, as we will demonstrate. LPCR reduced this possibility
greatly since ,5% of insertion sites are .5 kb. Additionally, our
primers are designed to avoid nuclear genome amplification; each
primer set is specific for the mtgenome as verified by BLAST (refer
to methods). We completed sequencing using the 454 GS FLX
system by pooling 12 individually tagged samples into each lane of
a 4-region gasket PicoTiterPlate (PTP). Two YRI samples
(NA19209 and NA19116) were discarded from analysis as both
samples showed only one of three amplicons with an unusually
high number of sites containing two different nucleotides at high
frequencies; this could have arisen from a sample mixture. In
addition, two CEU samples (NA12750 and NA12872) were
removed due to suspected mislabeling. The results presented are
from the remaining 40 samples. On average, each sample had
10,554 reads with a standard deviation of 2,652 reads. The read
length distributions were similar and consistent across all samples;
the distribution across all 44 samples (including duplicates) show
read lengths across a wide range but 93.7% of them are between
200–300 bp. The average read length was 250 bp with a standard
deviation of 36 bp (Supporting Figure S1) so that the yield per
sequencing run was ,2.6 megabases (mb).
Algorithm for Data Analysis
Our approach for obtaining the mtgenome sequence was to
map quality filtered reads against the reference sequence (rCRS) to
identify homoplasmic and heteroplasmic variant sites. We also
introduce a novel method for de novo assembly of the reads into a
circular genome. An important consideration in our study was to
obtain high accuracy of the resulting called bases. We accom-
plished this by quantitative filtering of reads that were error prone.
We finally estimated an accuracy of the resulting sequence and an
analysis of its genetic features.
Read filtering. We used five filters that eliminated reads,
which were considered either redundant (that would falsely
increase accuracy) or inaccurate (that would correctly decrease
accuracy). These filters built upon an earlier study to eliminate low
quality data using objective criteria [30]. First, we eliminated
identical (clonal) reads preserving a single copy of each set. A
second filter eliminated reads containing at least one ‘‘N’’. In this
case, ‘‘N’’ is not an ambiguous base but one defined by 454 as the
inability to incorporate a nucleotide after three consecutive flows
in a sequencing run. Additionally, we excised the primer sequences
at the beginning and ends of forward and reverse complement
reads, respectively, leaving only the extended portion as part of
this filter. Third, we eliminated all reads that fell outside the 200–
300 bp range. A fourth filter discarded reads that did not map to
rCRS or mapped to more than one location. The final filter
eliminated reads that started and ended at the same position
(Supporting Figure S2). These are different from clonal reads in
that they were not identical in sequence, usually having a
substitution or insertion/deletion (indel) within the read. Support-
ing Figure S3 illustrates the breakdown of reads discarded through
the five filters and shows that the majority of them arose from
clonal reads (,15%), being outside the length range (,7%) or
having identical start-stops (,9%). On average, 32% of the initial
raw reads were eliminated.
Quantitative model for base calling. First, all quality
filtered reads were aligned to rCRS (GenBank ID NC_012920),
one-by-one using the BLAST algorithm [31]. Second, to identify
each base at each position we focused on four parameters that
affected the confidence of a call, namely, the fractional coverage
for a particular base (Q), the ratio of forward-to-reverse reads for
that base (r), the length of a homopolymeric (HP) stretch
containing the mtgenome position and, the rate of substitution
sequencing errors (l). To set optimum values for each of these
parameters (details below), we first compared each of the four sets
of duplicate pairs sequenced, obtained their consensus sequences,
and varied the parameter values until these samples showed
maximum concordance across their consensus. Specific positions
that did not meet the imposed threshold criteria were then
denoted as ‘Z’ (un-called positions).
Specific variants inferred in the mitochondrial genome, such as
those in primer sequences and homopolymeric runs of four
nucleotides or more were verified manually to avoid false positives.
As shown in Supporting Figure S4, the mismatch probability in
homopolymeric runs, estimated from all 40 samples, increases
exponentially for lengths greater than four and includes both true
substitutions and sequencing anomalies. Nevertheless, homopoly-
meric runs are known to be highly error prone due to overcalls
and/or undercalls inherent in the 454 base-calling software and
alignment artifacts [32]. For judging whether reads with a
secondary base at a specific position are sequence errors or
heteroplasmic sites we assumed a model of random errors along
the read. While the overall error rate is generally ,0.5% [32], we
assumed a more liberal value of 5% to obtain a greater confidence
in heteroplasmic calls. We used this probability to calculate the
expected number of substitution errors that could occur along a
single read, using a Poisson approximation, so that the modal base
would have 99% confidence. Positions that had secondary
coverage greater than this level were then classified as potential
heteroplasmic candidates for further verification. The parameter
thresholds for the primary base call, including indels, were: Q$0.5
(modal base), 106$r$1026 (at least one read in both forward and
reverse directions), HP#4 and l=0.05. For putative hetero-
plasmic sites we adopted the following thresholds for the secondary
base call, including possible indels: Q$0.8 (80% of leftover
coverage), 12$r$1/12, HP#4 and l=0.05.
Error and performance. To assess the quality and accuracy
of the sequencing data, four sets of duplicates were sequenced: two
from each population (NA10851, NA10856 from CEU; NA18500,
NA18503 from YRI). Each duplicate was processed in a different
region of the PicoTiterPlate (PTP). The concordance in the
sequence was 100% for all sites and was based on analysis of
16,568, 16,567, 16,527 and 16,569 nucleotide positions in
NA10851, NA10856, NA18500 and NA18503, respectively, or
an error rate ,1.5161025 (zero changes in 66,231 bp). The
remaining positions were not called due to failing any of the four
parameters set to call bases confidently. These four samples
differed from the rCRS at 16, 30, 51 and 40 nucleotide positions,
respectively. These data served as evidence to support that 454
sequencing technology together with our algorithm was robust and
sufficient for accurate base calling. In addition, we compared the
mtgenome sequences of four additional samples that were also
sequenced using Sanger sequencing. In this analysis, the samples
NA06994, NA12146, NA18516 and NA18523 showed site
discordances of 0, 1, 8 and 4 nucleotide positions based on
16,567, 16,567, 16,196, 16,195 positions analyzed, respectively, an
error rate of 19.8461025 (13 changes in 65,525 bp). This .10-
fold difference in sequencing error demonstrates that the high
coverage obtained from pyrosequencing provides very accurate
data and that comparisons to Sanger sequencing create more
differences due to inaccuracies in the latter. This statement was
supported by comparing our results to the 1000Genomes data [27]
(see below).
An additional indication of the accuracy of the sequence we
generated is indicated by the frequency of the non-modal base at a
given position across all samples. This provides a simple statistic
that indicates how frequently an incorrect base is called since, in
Mitochondrial DNA Sequencing of Reference Genomes
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the majority of the samples, any given base is likely identical to the
reference sequence. As shown in Supporting Figure S5, 16,462 of
the 16,569 (99.4%) positions have a non-modal base frequency less
than 1022, indicating that a modal base can be identified at these
positions without ambiguity ,99% of the time, given the ,120-
fold level of sequence coverage.
Finally, we compared two separate de novo assemblies of the
mtgenome (assembling the circular genome in the antegrade and
retrograde directions) versus the more standard procedure of
mapping reads against the rCRS, to identify potential algorithmic
discrepancies for further investigation and curation. Of the 40 de
novo assembled HapMap mtgenomes, 15 matched identically at
every position when the antegrade and retrograde assemblies were
compared to each other. In the other 25 cases, the ambiguities
between the antegrade and retrograde assemblies were attribut-
able to one base differences in homopolymer length calls,
particularly around position 309 within the D-loop (14 cases), or
to a CAFIE (carry forward and incomplete extension)-base-
insertion artifact associated with long cystosine-stretches (five cases
near position 309 and one case near position 16190). A consensus
de novo assembly was obtained by resolving the homopolymer
length ambiguities between forward and antegrade directions in
favor of the assembly with multiplicity value, m.0 in both the L-
strand and H-strand n-mers and then choosing the local base call
with the highest local total multiplicity (see methods). This rule
assumes that the 454 signal processing for homopolymer length
calls gives the correct length more often than the incorrect length.
Beyond a certain length, this assumption does not hold. We note
that our de novo assembly for each individual are not ‘‘correct’’,
but do represent the compact summarizing of the 454 read data in
its raw form without risking artifacts incurring mapping reads to
the rCRS reference or the utilization of 454 sequence quality
scores. In the general case, the ambiguities in longer homopoly-
mers cannot be resolved without resorting to other sequencing
methods with non-overlapping systematic base-call-error process-
es. In certain coding regions, homopolymer sequence length
ambiguity may be resolvable by requiring, as an ad hoc rule, that
the entire sequence for a protein code for a valid protein. Finally,
the de novo assemblies were compared to those obtained by the
mapping approach, and in all cases, the discrepancies were
restricted to homopolymer length ambiguities as expected.
Characteristics of mtgenome Variation
The overall quality of the data is summarized in Figure 1. It
portrays normalized coverage and the 0-centered ratio of forward/
reverse reads at each position of the mtgenome. The average
coverage across all 40 samples in YRI and CEU was ,120-fold.
However, the total number of reads varied per sample so that we
normalized coverage by a sample’s total number of reads. Second,
we assessed the directionality bias in the reads by computing
r= (r21)/(r+1) where r is the ratio of forward to reverse reads at a
position. We present data on normalized coverage and read ratio
as an average across the 20 samples for each population, YRI and
CEU respectively. This is displayed along the mitochondrial
genome (Figure 1) as a function of local GC-content, calculated
using a sliding window of length 51 bp (25 bp before and after
each position) across the circular genome. The figure also
illustrates where the D-Loop and amplicons lie along the
mitochondrial genome. As can be seen, the average coverage falls
and the read ratio spikes prior to the PCR amplicon overlap
regions in both populations. However, r fluctuations are not due
to variations in GC content.
Frequency of polymorphic sites across the genomes. We
analyzed polymorphic sites per position and per mitochondrial
region as shown in Figures 2A and 2B. Figure 2A shows all the
variants found for all 40 mitochondrial sequences. Variants are
defined as positions where the primary base differs from the
reference rCRS, and are classified by population and location
across the mtgenome. Variant sites are further classified as known
or novel, depending on whether or not they are recorded in the
Mitomap database [7]. Overall, 418 individual variant sites
(substitutions and deletions) were found across the whole
mtgenome (2.6% of the entire mtgenome), including coding and
non-coding regions. These sites were seen 1,069 times and 446
times in YRI and CEU, respectively. The higher frequency of
variants found in YRI samples compared to CEU samples is
expected due to their older population age. Figure 2A clearly
shows that the majority of the variants found have already been
reported in Mitomap, for both CEU and YRI. This is not
unexpected since with a sample of ,20 individuals per population
the majority of recognized variants are likely to be common.
Additionally, all polymorphic sites found at high frequency were
previously reported in Mitomap for both populations. Novel sites
were only found at low frequency; most of these were found in less
than 3 individuals per population. It is evident that increased
generation of sequencing data has also resulted in an increase in
the number of sites reported to be polymorphic in mitomap: thus,
only 28 and 12 sites had not been previously reported for YRI and
CEU, respectively. Of the 418 sites, only 4 were deletions, 2 of
which were common for both populations. The rest of the sites
were substitutions, the majority of which were transitions (278 and
163, YRI and CEU respectively). The ratio of transitions:transver-
sions for all variants found, including known and novel, was 19.9:1
for YRI and 20.4:1 for CEU. This corresponds well with the
values found across all populations in mtDB (19.2:1) [33], when
transitions and transversions found in at least 0.2% of a sample
size are considered, and by the previously reported ratio of 21.2:1
when considering only variants over the 0.1% frequency in the
population [34].
The distribution of polymorphic sites per mitochondrial
genomic region is shown in Figure 2B. Frequency was calculated
as the number of positions found to be polymorphic for a
particular region divided by the length of that region and then
dividing again by the population size; positions were counted only
once. As published previously, a high frequency of the polymor-
phic sites is found in the D-loop region as compared to other
regions across the mtgenome in both populations [8,9]. The D-
loop contains 24.2% of the sites even though it is only 6.8% of the
mtgenome.
To assess the accuracy of the obtained consensus sequences we
compared our data to published sources [26,27]. Concordance
with HapMap II genotype data [26] was assessed for the 40
samples. For duplicates, the sequence with the highest call rate was
used for comparison. HapMap II data was available for 210 SNPs.
The majority of samples in the HapMap II data had a call rate
higher than 98%, with the exception of five samples that had a call
rate between 60–76%, giving an average call rate of 95.369.2%
and 95.4611.5% for CEU and YRI, respectively. The discor-
dance rate was 0.05% for YRI and 0.4% for CEU. For the
1000Genomes genotype data [27], including that at heteroplasmic
sites, information was available for 11 overlapping samples out of
our 40 samples (5 CEU and 6 YRI). We compared all available
genotype calls, excluding those in the error-prone homopolymeric
regions where we do not provide calls, to demonstrate high
concordance for all 11 samples: 8 samples were completely
concordant with the remainder showing discrepancies of 2/69, 2/
82, 3/69 variant sites. These results provide further support for
the improved performance of pyrosequencing and our calling
Mitochondrial DNA Sequencing of Reference Genomes
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algorithm, even when compared to 1000Genomes data where numt
contamination is a real possibility [28]. When comparing the
discrepant sites obtained by Sanger chemistry for NA18516 and
NA18523, 1000Genomes and our pyrosequencing data were
100% concordant. This suggests that the previously found
discordances between our data and Sanger sequencing were in
fact due to the inability of Sanger sequencing to pick up such
variation even if high quality traces are obtained (Supporting
Figure S6).
Heteroplasmy. Due to the resolution of next generation
sequencing technologies across the entire mtgenome, it was
possible to detect single nucleotide heteroplasmy even at low
levels, which in our case is ,10%. As mentioned earlier, in order
to be sure that the heteroplasmic sites being detected were
biologically real and not due to sequencing artifacts, we used a
stringent set of criteria to call secondary bases with high
confidence. Based on the chosen analysis parameters and
thresholds, we were able to identify potential heteroplasmic sites.
The first list of such sites was further condensed by manual
curation to filter out sites that were likely the result of PCR
artifacts or misalignment issues, especially at homopolymer
regions. Special attention was paid to polymorphic sites within
primer sequences. The latter problem arises because the reference
base, the base contained in the primer, starts accumulating in the
PCR product resulting in an artificial secondary base. These sites
were thus regarded only as variants. Furthermore, any sites in
which one of the two bases was a deletion were not taken into
account. Due to alignment issues and base calling errors at
homopolymeric runs discussed previously, any sites that showed
two bases at the end of homopolymer stretches were also excluded.
Overall, 71 sites were found to be heteroplasmic across all
samples (Supporting Table S1). Curiously, CEU samples had a
higher number of heteroplasmic sites per sample than the YRI
samples. As shown in Figure 3A, most samples had between 0 and
3 heteroplasmic sites; only three samples showed more than 9
heteroplasmic sites, all of them in CEU. In 14 of the 40 samples,
no heteroplasmic sites were identified. 58 positions were found to
be heteroplasmic in at least one sample in the CEU population,
two of those were seen in two different samples. YRI, on the other
hand, had only 13 heteroplasmic positions, all of which were seen
only once. Only one position was found to be heteroplasmic at
least once in each population. As shown in Figure 3B, the detected
levels of heteroplasmy ranged from 9% to ,50% (average 22%).
Figure 3B also shows the levels of heteroplasmy across the
mtgenome for each population. Interestingly, heteroplasmic
positions do not seem to cluster in the D-loop like other SNPs.
Taken as whole, levels of heteroplasmy were higher than expected
but consistent with recent studies [24,25], except for five samples
Figure 1. Coverage across the mitochondrial genome. The top portion of the figure shows where the three amplicons lie and overlap across
the mtgenome. A) Coverage for all samples per population. For each sample the coverage at a particular position was normalized by dividing the
total number of reads obtained for that sample by 1,000. B) The forward to reverse read ratio for the modal base was centered to 0 using the
following statistic: [(forward/reverse)21]/[(forward/reverse)+1]. C) GC content across the mtgenome was calculated using a sliding window of 51 bp
centered on the position in question.
doi:10.1371/journal.pcbi.1002737.g001
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containing more than three heteroplasmic sites (Figure 3A). It is
noted that while these may occur biologically, these anomalies
may have arisen from two other scenarios: (1) mutations within the
lymphoblastoid cell lines used as a DNA source for our
experiments, or (2) inadvertent sample mixtures. Further blood
samples would have to be investigated to rule out case 1. A
detailed haplotype analysis was conducted for the 40 samples to
rule out case (2) of mixtures within the 40 samples. Briefly, the
SNPs involved did not map to different mitochondrial lineages
suggesting that mixture of samples was unlikely.
Our additional analysis however supports the heteroplasmic
sites we have identified. First, comparison of the four sets of
duplicates showed concordance in the candidate heteroplasmic
positions found, three of them having one such site (NA10851,
NA10856, & NA18500). The only difference within each set was
the ratio of secondary base to primary base which varied by 3%,
9% and 8% for NA10851, NA10856, & NA18500, respectively.
To further check the validity of the heteroplasmic sites identified
we checked the positional distribution of each heteroplasmic site
along a read. The assumption driving this test was that true
heteroplasmic sites should be distributed evenly across reads – at
the head, in the middle and at the tail. On the other hand, false
positives would be clustered either at the head or at the tail of a
read because the quality of the reads decreases at the end of reads.
Supporting Table S2 shows examples of true positive versus false
positive sites. For most of the sites, the standard deviation of the
positional distribution for the non-reference base at that site
ranged from 0.6 to 6 and 0.6 to 10 in YRI and CEU, respectively.
In YRI there were three outliers with standard deviations of 13, 14
and 48. CEU had 6 outliers, with standard deviations in the range
12–41.
We performed Sanger sequencing in an attempt to validate all
71 heteroplasmic sites (Supporting Table S1). 22.5% of the sites
could not be validated due to poor quality of the sequencing data
covering that position. Of the remaining 55 sites covered by at
least one good quality read, we were able to validate 17 (29%). Of
these 17, 7 were sites with low heteroplasmic levels (10%–19%).
Supporting Figure S7 (A–G) shows Sanger sequence chromato-
grams for some of the validated sites. Surprisingly, this set also
includes sites with a high level of heteroplasmy (.35%). For
example, position 1333 in NA10851 did not have two bases in the
chromatogram the first time we tested it. However, testing by
Figure 2. A. Frequency of polymorphic sites by population across the mitochondrial genome. The top portion of the figure shows the
physical locations of the amplicons with overlap across the mtgenome; red and blue dots represent YRI and CEU samples, respectively. Frequency of
known polymorphic sites for all samples by population showed on top, and frequency of novel polymorphic sites by population on bottom. The term
‘known’ refers to sites that are listed in mtDNA databases and the term ‘novel’ refers to sites that have not been previously described. B. Frequency
of Polymorphic sites per mitochondrial genomic region. Red and blue bars represent YRI and CEU, respectively. Frequency was calculated by
dividing the number of polymorphic sites found in each region by the length of that region and then dividing again by the sample size. Each site in a
region was counted only once.
doi:10.1371/journal.pcbi.1002737.g002
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Taqman genotyping provided evidence supporting two bases at
position 1333. In a repeat experiment using Sanger sequencing we
could clearly see two peaks at that position (Supporting Figure S7 B).
Therefore, it is evident that we cannot rely on Sanger sequencing
results for validation of heteroplasmic sites but need an alternative
technology tested on mtgenomes purified in the same manner as
ours. While the rest of the sites did not appear heteroplasmic in the
chromatograms, we are confident they were true sites according to
our calling parameters and the large numbers of reads supporting
these calls. We also compared the status of heteroplasmy for our 11
samples that overlapped with 1000Genomes data [27]. 1000Ge-
nomes called 5 sites as heteroplasmic, 3 of which are concordant
with our heteroplasmy calls. Two of them are at low levels, at 16%
and 17%, while the third is at 36%. The other two sites were called
only as variants by our algorithm. One of the concordant
heteroplasmic sites was not validated by Sanger sequencing, which
further supports the idea that Sanger sequencing is not appropriate
for validation of heteroplasmy.
To provide further evidence supporting the accurate calling of
heteroplasmy by our method, we sequenced Standard Reference
Material (SRM) 2394, developed by the National Institute of
Standards and Technology (NIST) [21], by both Sanger chemistry
and 454 pyrosequencing. SRM 2394 is designed to simulate
different levels of heteroplasmy by mixing two 285 bp mitochon-
drial amplicons obtained from two different human cell lines.
These two amplicons differ by only one nucleotide. There are
eight different mass percentages of the polymorphic mixtures,
namely 1%, 2.5%, 5%, 10%, 20%, 30%, 40%, and 50%. As
shown in Supporting Figure S8, there was strong correlation
(R2 = 0.96) between our algorithm’s observed heteroplasmic levels
and the true values. This provides additional evidence that
heteroplasmy can not only be detected but also accurately
estimated at levels as low as 10%. The results of Sanger
sequencing were used to visualize the different mixtures and their
proportions. As expected, the chromatograms were able to resolve
mixtures of 30%–50% very well; however, mixtures of 10% and
Figure 3. A. Heteroplasmic sites per sample. Total number of heteroplasmic sites found per sample for each YRI and CEU sample. B. Level of
heteroplasmy per position across the mitochondrial genome. Top and bottom displays the level of heteroplasmy for all sites found in YRI and
CEU samples, respectively, across the mitochondrial genome.
doi:10.1371/journal.pcbi.1002737.g003
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20% were barely detectable and would have been dismissed as
noise if we had no previous knowledge of these mixtures.
Discussion
The human mitochondrial genome can be sequenced at very
high accuracy and rapidly using next generation sequencing
technology as we, in this study, and other recent studies [24,25],
have shown. All of these studies have in common that they have
uncovered patterns of sequence variation as has been described
before but quantified the novel finding of a high rate of
heteroplasmy in multiple individuals and across the mtgenome.
Our study, however, has made three additional and important
contributions. First, we have sequenced widely and publicly
available biological samples so that our experiments can be
replicated and provide a basis for future benchmarking and
technology comparisons. Second, our methodology for variant and
heteroplasmy detection is quantitative and parametric so that the
method can be further optimized with additional experiments and
new data. Third, we have developed a method for de novo sequence
assembly of the mitochondrial circular genome with an internal
test of sequence accuracy (identity of antegrade and retrograde
assembly along a circular genome).
Each of the above developments is significant for understanding
mitochondrial biology and medicine. First, DNA sequencing
technology is advancing and new platforms that include single-
molecule sequencing are on the horizon [35]. The availability of
multiple sequencing methods on publicly available biological
samples, such as those we have used, is the only certain way for
comparing different technologies and their relative advantages and
disadvantages. Second, we believe that the parameters we have
used for identifying variants and heteroplasmy will need to be
varied depending on the specific technology used and its features
such as directional bias, read accuracy, difficulty in reading
through homopolymeric tracts and coverage. Consequently, our
approach is general and generalizable. Third, mapping reads
against a reference suffers from the disadvantage of not being able
to confidently identify insertions or inversions. The de novo methods
we have introduced can rectify this deficiency particularly since
our preliminary exploration of 40 sequences suggests that it
produces high-quality assemblies.
The problems associated with recovery of target mitochondrial
DNA from a biological sample, its DNA sequencing using short
reads, the assembly of these reads into an mtgenome and its
interpretation of variation and heteroplasmy are invariably
confounded. We chose to recover the mtgenome in each
individual by three distinct long-range PCR segments, analogous
to Li et al. (2010) and in contrast to He et al. (2010). Our primers
are designed to specifically target mtDNA and avoid introducing
any artifacts from the numerous mitochondrial fragments (numts) in
the nuclear human genome. Even if there is indeed some
contamination from numts, this effect is expected to be small since
it is assumed that there are many more copies of the entire
mtgenome than two numts copies per the .1,200 autosomal
insertion sites. However, specific fragments are present in .100
copies and can, and do, get amplified [29]. We expect that single
molecule sequencing will reduce or eliminate this potential
technical artifact. It is currently popular to extract and assemble
the mitochondrial genome from whole genome sequencing of total
cellular DNA [27]; Picardi and Pesole (2012) have recently done so
from off-target exome sequencing data. But, these latter authors
also show that ,1% of all reads map to the mtgenome and not to
known numts! Consequently, extensive filtering may be necessary to
derive the mtgenome but this might also lose the genome-specific
features including heteroplasmic sites. In other words, comparison
of our data with those of others needs to consider how the mt
DNA was isolated in the first place.
In this study, we have made no attempt to estimate the cost of
sequencing a single mtgenome in any accurate way. In any case,
we have demonstrated that we can obtain such sequence rapidly
and with an error rate ,5.6361024. Our crude estimate is that
each sequence can be obtained for,$50 at high throughput much
of this cost being the cost of mt DNA recovery. If so, studies of an
entire cohort of individuals who have been measured for
numerous medically relevant traits and are being followed
for disease outcomes would be an ideal pilot experiment for
individualized medicine.
Materials and Methods
DNA Samples
Forty-four reference DNA samples of unrelated individuals from
the International HapMap project were studied using 454
pyrosequencing technology. The samples included 22 Yoruba
samples from Nigeria (YRI: NA18500, NA18503, NA18506,
NA18516, NA18523, NA18852, NA18855, NA18858, NA18861,
NA18870, NA18912, NA19092, NA19101, NA19116, NA19137,
NA19140, NA19152, NA19159, NA19171, NA19200, NA19203
& NA19209) and 22 Utah residents of European ancestry (CEU:
NA06993, NA06994, NA07019, NA10851, NA10854, NA10856,
NA10863, NA11831, NA11881, NA11882, NA11995, NA12004,
NA12005, NA12144, NA12145, NA12146, NA12156, NA12248,
NA12750, NA12760, NA12872 & NA12891), four of which were
studied in duplicate (NA18500 and NA18503 from YRI;
NA10851 and NA10856 from CEU). Additionally, four of these
samples were sequenced using Sanger sequencing and the
Affymetrix Mitochip Array 2.0 (NA06994, NA12146, NA18516,
and NA18523) for comparison. We also evaluated the Standard
Reference Material (SRM) 2394 developed by the National
Institute of Standards and Technology (NIST). These are a set of
eight mixtures (mass percentages of 1%, 2.5%, 5%, 10%, 20%,
30%, 40%, and 50%) of two 285 bp mitochondrial amplicons that
differ in sequence by only one nucleotide and is obtained from two
different human cell lines. After QC checks that detected sample
contamination, data from NA19209, NA19116, NA12750 and
NA12872 were dropped from further analysis.
Sample Preparation
For pyrosequencing, we enriched for the mitochondrial
genomic DNA by long range PCR (,5–6 Kb) for three
overlapping amplicons using high-fidelity TaKaRa LA Taq
(TaKaRa Biomedicals) in 50 ml reactions (50 ng gDNA, 16 LA
PCR buffer, 0.3 mM of each primer, 400 mM dNTPs, 2.5 U LA
Taq). The primer sequences used were those described in Maitra
et al (2004). Each primer set was blasted against the entire human
genome to verify that there was no nuclear genome amplification.
In silico PCR also confirmed no nuclear genome targets
amplification by any of the three distinct primer sets. The success
of the amplification reaction was checked by gel electrophoresis.
The PCR products were then cleaned using the QIAquick PCR
purification kit (QIAGEN) following the column purification
protocol and the DNA was eluted in 30 ml of Elution Buffer to
obtain a higher concentration. The actual concentration was
determined using the Quant-iT PicoGreen dsDNA kit (Invitro-
gen). To obtain a uniform representation of the entire mtgenome,
the amplicons were pooled in equimolar amounts (amount per
amplicon [ng] = fraction of total x total amount needed). Since the
pyrosequencing protocol required more than 5 mg of total DNA at
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a concentration of 300 ng/ml we performed at least two PCR
reactions per amplicon. After pooling the three amplicons per
reference sample in equimolar amounts, the samples were run
through a QIAquick purification column to concentrate the pool
to the desired 300 ng/ml concentration.
For Sanger sequencing, the mtgenome was amplified in 24
overlapping PCR fragments (800–900 bp) as described in Rieder
et al 1998. For easy detection during sequencing, M13 tags were
added to all forward and reverse primer sets. PCR reactions and
cycling conditions were optimized across all primer sets and used
16PCR Buffer, 200 mM dNTP, 0.5 U Taq2000, 10 ng DNA, and
0.5 mM of each primer. Confirmation of the reactions’ specificity
was assessed by 2% agarose gel electrophoresis. The final
concentration of each amplicon was determined using the
Quant-iT PicoGreen dsDNA kit (Invitrogen).
DNA Sequencing and Primary Analysis
All sequencing using Sanger chemistry were performed by a
commercial entity (Agencourt) for each individual PCR product
on an automated ABI3730xl platform using a concentration of 15–
25 ng/ml in 30 ml of TE buffer; individual sequence traces were
provided. The Sanger sequence for each sample was assembled
and analyzed in the SeqManII program from the DNASTAR
LasergeneH v.7.0 analysis software suite. All sequencing reads for
an individual sample were imported and assembled into one
contiguous consensus sequence by aligning them to the revised
Cambridge Reference Mitochondrial Sequence (rCRS). The
variant bases for each sample were determined and used as the
genotype for that sample for further analysis. Peak intensities for
each sequence variant identified by the program were manually
reviewed.
For pyrosequencing of the 48 samples, including duplicates, we
pooled the pooled long range PCR products per sample in four
batches of 12 each using 454’s Multiplex Identifiers (MID) that are
molecular barcodes that serve as unique tags to identify each
sample post-sequencing. These mitochondrial DNA pools were
sequenced on a 4-gasket PicoTiterPlate (PTP) using the GS FLX
sequencing system. Standard emPCR and sample preparation
were followed as recommended by the manufacturer (Roche Inc.)
Modified BLAST to Improve Alignment
As an additional precaution against misalignments, we devel-
oped an improved version of the BLAST algorithm. BLASTN uses
an affine gap costs model and allows control of gap opening, gap
extension and mismatch penalties and are particularly problematic
for homopolymer stretches due to undercalls and overcalls. To
accurately align these reads against a reference sequence, we
needed an aligner that adjusts the gap penalties depending on the
presence and length of the homopolymer sequence. The standard
Smith-Waterman algorithm for aligning two sequences can be
extended to handle these situations as follows. Let c(n,m) be the
penalty for a n-length homopolymeric stretch of the reference
appearing as an m-length stretch in the read. Then, the dynamic
programming algorithm was modified to consult the c matrix also
when computing the optimal alignment of the sequences. The
entries of the c(n,m) matrix needed to be defined heuristically. In
the current study, we set c(n,m) such that in homopolymer
stretches of length $5, two gaps were ignored and the remaining
penalized using the standard affine gap penalty model of
BLASTN. In homopolymeric stretches of length 4, one gap was
ignored. Since the largest homopolymeric stretch in the mito-
chondrial sequence is only 8 bases long, these values in the c(n,m)
table were sufficient to yield good results. For performance
reasons, we carried out alignment first using BLAST. Portions of
the resultant alignment that were likely to benefit from our
homopolymer-aware aligner were identified and refined using a
Perl implementation of the model described above.
De novo Assembly of the Mitochondrial Genome
We developed an independent de novo assembly of each
mtgenome. In our approach, we initially populate a database
comprising all unique n-mers (n=27 here) and the frequency of
each n-mer in the raw read data. To populate the database we
slide a window, n bases long, along each read and record the
sequence within the window as the read is traversed. Starting at
the first base position, the n-mer comprising the first base and the
subsequent n-1 bases is recorded. The window position is then
incremented 1 base at a time until all n-mers from the read have
been entered into the database. If an n-mer sequence already
exists in the database, the number of occurrences (multiplicity, m)
is incremented by 1. As an example, the distribution of m over all
454 reads for sample NA06993 is shown in Supporting Figure S9.
The distribution is multimodal. The peak at multiplicity m=1
comprises all n-mers that contain one or more 454 sequencing
errors and that are not repeated as a group in any other read of the
particular region of the genome. The peak near m=50 is the mode
of the local, n-mer matched, consensus coverage of the genome.
The high multiplicities in the tail of the distribution are due to
genomic regions where the long PCR segments overlap.
To de novo assemble the mtgenome using the n-mer database
data, we make the following minimal set of assumptions: 1) there
are no duplicated n-mers within the genome; 2) there are no
palindromic n-mers, i.e., an n-mer on the L-strand of the
mtGenome is not found in reverse complement form on the H-
strand and vice versa, and 3) for a short n-mer drawn from the
genome, the sequence read of this n-mer is more likely to be
correct than contain an error. The third assumption depends on
the sequence-context-dependent error rate of the 454 platform. If
we consider as a characteristic value, l=0.005, for the average
454 error rate per base, then for any n-mer, the probability that
the n-mer is error free is given by p= (12l)n. If we choose n=27,
this gives p=0.87. This means that a majority of database n-mers
are correct given that most of the mtgenome sequences are
‘‘average in content’’. This calculation assumes errors are
uncorrelated along the n-mer, which is not the case for the sequence
context of long homopolymeric runs (see below). Our choice of n= 27 is a
compromise value that seeks to ensure the validity of assumptions
1–3: the shorter an n-mer is, the more likely it is to be repeated in
the mtgenome or be a palindrome; on the other hand, if the n-mer
is chosen to be too long, the majority of n-mers derived from reads
at a given genome position will contain an error somewhere within
the n-mer. The satisfaction of assumption 3 allows us to apply a
‘‘majority base wins’’ criterion as our basis for selecting sequences
in our de novo consensus assembly.
The de novo assembly initially proceeds by searching the
database for the n-mer matching at position 1 on the L-strand
of the rCRS and ensuring the multiplicity m for L- strand and H-
strand sequences at this position exceed 10. This starting condition
was satisfied for all mtgenomes assembled (i.e., no genome
contained a polymorphism with respect to the rCRS in this
portion of the genome, otherwise successive positions along the
rCRS could readily be probed until this condition was satisfied).
First, de novo assembly proceeds in the antegrade direction (with
increasing rCRS position). We form the four possible candidates
for the successive n-mer in the sequence and their respective
reverse complements by dropping the first base of the n-mer at
rCRS position 1 and adding A, T, C, or G to the end. The
database is then searched for each candidate n-mer and its reverse
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complement, and the sum of the respective forward and reverse n-
mer multiplicities is recorded for each candidate n-mer. According
to assumption 3), the appropriate choice of the subsequent n-mer
is the one that is the most abundant in the database. The selected
new base is then added to the de novo assembly and the process is
repeated until the starting n-mer sequence at rCRS position 1 is
again encountered (exploiting the circular nature of the mtge-
nome). The antegrade de novo assembly is then complete. To assign
consensus coverage at each base position we form the n-mer from
the antegrade assembly in which the position in question is at the
center, with (n_mer-1)/2 bases on either side. The database is then
searched for this n-mer and the sum of the L-strand and H- strand
multiplicites, m, is recorded as the consensus coverage.
As a check on the antegrade de novo consensus assembly, the
entire assembly process above is repeated by sequencing from
rCRS position 1 in the retrograde direction using the same
database. Here, the base at the end of the L-strand n-mer is
dropped and the candidate n-mers for the next position in the
retrograde direction are formed by adding A, T, C, or G to the
beginning of the n-mer. The alternative assemblies in the
antegrade and retrograde directions are subsequently compared
to identify discrepancies for further investigation and curation.
Substitution heteroplasmy candidates, and their respective
fractions with respect to the consensus sequence, can then be
determined by replacing the central base at each position with the
other three possible bases, and then summing the L-side and H-side
multiplicities of the n-mers in the database. Indel heteroplasmys
with respect to the consensus can also be determined using a method
aligning the unused n-mers in the database against the consensus.
Supporting Information
Figure S1 Average read length distribution for 40
samples including duplicates. After removing clonal reads,
the average read length was 249.9 nt with a standard deviation of
36 nt; 93.7% of reads were between 200 and 300 nt long.
(TIFF)
Figure S2 Example of reads located in primer overlap
between amplicons 2 and 3 for sample NA18870. A) All
reads spanning the overlap region of amplicons 2 and 3. B) Reads
remaining after eliminating those that start and end at the same
position. The discarded reads are not identical to each other.
(TIFF)
Figure S3 Quality control (QC) filters. Reads were filtered
using five different criteria to retain only high quality reads by
removing: 1. clonal reads; 2. reads containing at least one N (N does
not indicate an ambiguous base but is defined as an instance when a
nucleotide was not incorporated after three consecutive flows in a
sequencing run); 3. reads longer than 300 or shorter than 200 nt based
on the read length distribution observed across all samples; 4. reads
mapping to multiple locations or not mapping to the mitochondrial
genome; and, 5. reads of equal length starting and ending at the same
positions but not identical to each other. On average 68% and 66%
were preserved for CEU and YRI, respectively.
(TIFF)
Figure S4 Sequence error as function of homopolymeric
region. Homopolymer stretches were grouped by length and the
total number of non-consensus bases within each stretch was
divided by the total number of bases in that group. The probability
of having a substitution or mismatch (majority are deletions)
exponentially increases in homopolymer regions of length greater
than 4 nt. Final positions in such regions were not called due to
this intrinsic error in the 454 pyrosequencing base-calling
algorithm along with the BLAST alignment.
(TIFF)
Figure S5 Fraction of total non-consensus bases. The
fraction of total non-consensus bases was calculated by dividing
the total number of non-consensus bases at a particular position by
the total number of bases seen at that position. The results indicate
that 99% of all positions have secondary coverage fraction less
than 1.761022, 2.161022 for YRI, CEU respectively.
(TIFF)
Figure S6 Sanger sequencing chromatograms for sam-
ple NA18516. The traces show the region containing 8
discrepancies between pyrosequencing and Sanger sequencing
data. The pyrosequencing calls are also supported by 1000Ge-
nomes data. The whole region is covered by high quality bases.
(TIFF)
Figure S7 Sanger sequencing chromatograms showing
heteroplasmic sites. Sanger sequence traces showing valida-
tion of both lower (10%–19%) and higher (.20%) level
heteroplasmic sites. A) Bases around position 13328 for sample
NA07019. Position 13328, next to the blue line, has two bases,
namely a C and a T. The level of heteroplsmy for this site was
calculated as 13% in our analysis. B) Position 1333 in sample
NA10851 has two bases, G and A at almost 50%, close to the 42%
in our analysis. C) Position 7925 in sample NA10863 next to the
blue line, has two bases, G and A; calculated at 36% D) Position
251 in sample NA12145 next to blue line has two bases, G and A;
calculated at 34%. E) Position 8512, next to blue line, shows a
lower level heteroplasmic site (16%), A and G. F) Two traces
covering the region around position 2274, show A and G
heteroplasmy at that site, calculated as 36%. G) Position 7364 in
sample NA19152 showing both A and G, calculated at 40%, and
H) Position 1552 in sample NA19203 showing G and A, calculated
at 48%.
(TIFF)
Figure S8 Accuracy of heteroplasmy detection. The
Standard Material (SRM 2394) is designed to simulate different
levels of heteroplasmy by mixing two 285 bp amplicons obtained
from two different cell lines which differ by one nucleotide in the
following mass percentages: 1%, 2.5%, 5%, 10%, 20%, 30%,
40%, and 50%. The graph shows the strong relationship between
the true versus estimated mass percentage with coefficient of
determination R2= 0.96.
(TIFF)
Figure S9 n-mer multiplicity. Frequency of occurrence
(multiplicity) of n-mers for n= 27 obtained from 454 reads from
a single HapMap sample (NA06993).
(TIFF)
Table S1 Heteroplasmic sites and validation status by
sample. The table provides for each heteroplasmic site its
position, the relevant bases, coverage, heteroplasmic frequency,
validation status and whether it was also identified in 1000Ge-
nomes. A) Heteroplasmic sites found in YRI samples and B) CEU
samples.
(DOCX)
Table S2 Positional distribution of a particular hetero-
plasmic site along a read. The symbol c( ) is used to count the
number of times the primary base at any position is found at the
beginning, middle or end of a read, and d( ) is used in the same
way for counts of the secondary base at that position. A) Two
strong heteroplasmic candidate sites showing a uniform positional
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distribution. B) Three artifactual heteroplasmic candidate sites
displaying a biased distribution along the read. These sites are all
contained in primer sequences.
(DOCX)
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